Sep 2026· Journal of Clinical Technology and Theory· Vol 4, pp. 27-42· 0 citations
TL;DR
The findings demonstrate the effects of gut microbiome dysbiosis on the progression of rheumatoid arthritis, providing a connection to clinical diagnostics and therapeutics and the presence of numerous uncertain variables means that scientists have not yet developed a fully validated and comprehensive diagnostic and therapeutic protocol that can be fully trusted.
Abstract
This dissertation investigates how the gut microbiota impacts Rheumatoid Arthritis (RA), a project that spans three core disciplines: rheumatology, microbiology, and immunobiology. It first outlines the key changes in the gut microbiome observed in rheumatoid arthritis. It also examines possible mechanisms linking the gut to joint inflammation, such as impaired intestinal barrier function and ongoing inflammatory processes. In addition, the potential use of the gut microbiome as a diagnostic biomarker is considered. The findings demonstrate the effects of gut microbiome dysbiosis on the progression of rheumatoid arthritis, providing a connection to clinical diagnostics and therapeutics. The literature review elaborates on the autoimmune nature of RA, details its inducing factors—genetics and the environment—and explains how serum biomarkers and the mucosal hypothesis link inflammatory responses to microbial dysbiosis, in turn triggering abnormal autoimmune activity and ultimately leading to the onset of the disease. The discussion section conducts a two-sided analysis of existing medical technologies for RA diagnosis and treatment, evaluating their promising prospects. For instance, the detection of several bacterial taxa with significant abundance changes enables the identification of the disease in patients at the early stage or even before its onset, and targeted probiotic supplementation and drug administration can be adopted to ameliorate microbial dysbiosis. At the same time, the limitations of existing studies, such as one-sided research outcomes caused by the failure to account for all confounding variables, are also pointed out. The dissertation concludes that current medical advances have achieved effective improvements in mitigating RA's adverse impact on human health. However, the presence of numerous uncertain variables means that scientists have not yet developed a fully validated and comprehensive diagnostic and therapeutic protocol that can be fully trusted. The compilation of this dissertation is based on the analysis of literature on RA itself and related clinical test reports, together with personal perspectives formed throughout the research process.
Current evidence supports the gut–joint axis as a promising framework for understanding immune dysregulation in RA and highlights microbiota-targeted interventions as potential adjunctive therapeutic strategies.
Shirin Hafezi, Fatemeh Saheb Sharif-Askari, Narjes Saheb Sharif-Askari et al.· Frontiers in Immunology· 0 citations
Osteoarthritis is a degenerative disorder of the whole joint and the leading cause of chronic disability in older adults, yet no disease-modifying therapy exists. Here we review what the gut microbiome teaches us about how osteoarthritis develops and progresses. We outline a biologically plausible gut-joint axis in whi...
G. Dyson, C. Brawner, Matlock A. Jeffries· Baillière's Best Practice &...· 0 citations
Psoriasis is a chronic inflammatory skin disease driven by the IL-23/IL-17 axis. Evidence accumulated over the past decade indicates that its pathogenesis extends beyond the skin and involves bidirectional communication between the intestinal microbiota and host immunity. This narrative review organizes current evidenc...
There is growing interest in the role of the gut microbiome in immune development and homeostasis during childhood. Increasing evidence suggests that early alterations in microbial composition might influence susceptibility to both respiratory and rheumatic diseases through interconnected pathways. While the gut–lung a...
Lisa Gazzolari, Laura DiDomenico, Natalie Leone et al.· International Journal of Mol...· 0 citations
Gut microbiome modulation is not yet ready to replace conventional AD therapies, but represents a promising complementary strategy that warrants continued rigorous investigation, and expert recommendations for future research are made.
Xiao-Yuan Cui, Chao-Fan Li, Hai-Long Zhang et al.· Archives of Dermatological R...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.